MedLern Secures Strategic Investment from Leading Medical Training Providers HQR Systems, Inc. and Laerdal Medical for Indian Expansion
In a significant development that sets the stage for a new era in Healthcare Training in India, the American Heart Association’s subsidiary Healthcare Quality and Research Systems, Inc. (HQRS), and Laerdal Medical have invested in Medlern, the country’s full-stack healthcare training platform, meaning it supports the front- and back-end of the educational sites and applications.
Impelsys, the American Heart Association (Association) and Laerdal have worked closely together for a decade, through a collaboration with Impelsys – MedLern’s parent company. MedLern serves nearly 400 hospitals and over one lakh hospital workers in India, delivering a million hours of training through its innovative solutions. MedLern is helping improve hospital bottom-lines through driving Nursing Excellence, Service Excellence, Patient Safety and Experience in leading hospitals in the country. MedLern deploys digital tools, content, simulation devices and experts to embed systematic and structured training in Hospital’s business operations.
“We couldn’t have asked for better collaborations at this stage of growth. HQRS and Laerdal bring the latest innovations and evidence-based tools and content to drive high quality training in healthcare settings globally. India’s healthcare sector needs to leapfrog the world in innovation to create the skilled manpower to serve the largest and most diverse demographic in the world. We need scale and vision. We are seeing hospital leaders break away from an ad-hoc and just-in-time approach to training to adopt our scalable solutions. The new collaborations open up access to an impressive pipeline of healthcare training innovation are we are committed to make this affordable and rewarding for hospital leaders in India,” said Mr. Deepak Sharma, Co-founder and CEO, MedLern.
“Every year, nearly a hundred thousand Indian doctors, nurses and other healthcare professionals are trained on the Association’s BLS, ACLS and PALS programs but that is still a small fraction of what the country needs. With MedLern’s support, we believe we will have the scale to reach our solutions to the wider ecosystem and save many more lives. In the US, we train 22 million people in CPR every year and in the last 5 years alone, we have helped reduce deaths from stroke by 13.6 % and deaths from heart disease by 14.1%. We are also very excited about the prospect of bringing our portfolio of evidence-based tools, guidelines and CME content to benefit the Indian ecosystem in the future” said Mr. John Meiners, of HQRS and Chief of Mission Aligned Businesses & Healthcare Solutions at the American Heart Association.
“Laerdal has a deep commitment to India and we have been serving Hospitals, Educational Institutions, not for profits and government entities to further our mission of Helping Save Lives. Globally, we achieve this through advancement of resuscitation, patient safety and quality of healthcare, and saving lives at birth in low-resource settings. We work with enabling technologies, collaborative initiatives, and early interventions with high life saving potential and low cost to society. Our strategic investment in MedLern brings us closer to bringing scalable solutions to a developing market in the most populous country in the world.” said Mr. Alf Christian Dybdahl, CEO of Laerdal Medical.
Mr. Sameer Shariff, founder of Impelsys and Chairman and Co-founder of MedLern said, This is a significant step in our mission to work together to bring the best quality of global healthcare to India. I believe India has the potential to not just improve the quality of healthcare delivery to its own citizens but also contribute to the future of global healthcare. I am looking forward to the exciting and impactful journey ahead.”
Laerdal Medical is a world leader in healthcare education and resuscitation training. By using immersive technologies and data-centric insights they help to increase survival and improve healthcare quality. They empower lifesavers, and healthcare workers, to help them save more lives and have a goal to help save 1.000.000 more lives, every year, by 2030.
The investment in MedLern is made through the organization’s wholly owned subsidiary, Healthcare Quality and Research Systems, Inc. (HQRS). American Heart Association is the oldest and largest voluntary organization dedicated to fighting heart disease and stroke in the USA. Founded nearly a hundred years ago, it is served by 35 million volunteers and 2,900 employees united by their shared focus on cardiovascular health. It has invested more than 5 billion USD in research, advocacy, tools and training since 1949.
Impelsys is a purpose-driven company with the vision to make the world a better place by helping spread knowledge through technology. With more than 20 years of experience, 1,000+ experts and over 2,500 tailormade solutions built for its clients, Impelsys works at the intersection of business and technology to help clients succeed. Its expertise in technology solutions, eLearning services, and digital content delivery platforms has allowed it to prepare its clients for the challenges and opportunities ahead.
———————————————————————————
About MedLern:
MedLern is a digital training platform for hospitals & healthcare professionals. It is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. MedLern offers reliable & up to date learning resources and technology to healthcare professionals and enables them to deliver the best in healthcare by consistently upgrading their skill set. MedLern has been working with more than 400 hospitals, 100,000 healthcare professionals and over 150 nursing institutes with their training and development needs. It can be your one-stop digital solution to address – Talent and Training Management, Staff Productivity, Professional Development & Compliance Training. Bringing world-class e-Learning modules from the world’s best content providers, MedLern is the preferred choice for some of the leading hospitals in India, South Asia and the Middle East.
